The effect of valsartan combined with ginkgo biloba extract in the treatment of early diabetic nephropathy
10.3760/cma.j.issn.1673-4904.2010.07.006
- VernacularTitle:缬沙坦联合银杏叶提取物治疗早期糖尿病肾病的临床研究
- Author:
Lei CHU
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathies;
Ginkgo biloba extract;
Valsartan
- From:
Chinese Journal of Postgraduates of Medicine
2010;33(7):16-18
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of valsartan combined with ginkgo biloba extract (EGB) in the treatment of early diabetic nephropathy (DN). Methods All of 112 cases of early stage DN patients were randomly divided into treatment group (58 cases) and control group (54 cases). Two groups were given insulin to control blood gluoose and valsartan 80 mg/d. Meanwhile the treatment group was given EGB by intravenous infusion. The changes of urinary protein excretion rate (UAER), urinary β_2-microglobulin (β_2-MG), blood pressure, fasting glucose, serum creatinine (SCr), blood urea nitrogen (BUN), total cholesterol (TC), triglyceride (TG) were compared. Results There was no significant difference in UAER, β_2-MG, systolic blood pressure, diastolic blood pressure, FPG, BUN, SCr, TG and TC before treatment between two groups (P> 0.05). After treatment, they were improved in two groups compared with those before treatment(P < 0.05). Except for systolic blood pressure[(130 ± 13) mm Hg(1 mm Hg = 0.133 kPa) vs(129 ± 11) mm Hg], the improvement in treatment group was superior to that in control group(P<0.05). Conclusions Valsartan combined with EGB in treatment of early DN has significant synergies, and they can play roles with each other to prevent further deterioration of DN. This strategy is worthy to be popularized.
